Coca-Cola Amatil
Coca-Cola Amatil
Coca-Cola Amatil
| Type | Public |
|---|---|
| Traded as | ASX: CCL |
| Founded | 1904 |
| Headquarters | Sydney |
| Key people | Alison Watkins (Group Managing Director) |
| Industry | Beverage |
| Products | Soft drinks, bottled water, energy drinks, juices, and ready-to-drink coffee |
| Revenue | AUD 4.4 billion (2019) |
| Operating income | AUD 550 million (2019) |
| Net income | AUD 400 million (2019) |
| Employees | 12,000 (2019) |
| Website | [ccamatil.com Official website] |
Coca-Cola Amatil is a leading beverage company based in Sydney, Australia. It is publicly traded on the Australian Securities Exchange under the ticker symbol ASX: CCL. The company was founded in 1904 and has since become one of the largest non-alcoholic beverage manufacturers and distributors in the Asia-Pacific region.
History
Coca-Cola Amatil was originally established as the British Tobacco Company in 1904. It later changed its name to Amatil Limited in 1977 and finally to Coca-Cola Amatil in 1989 when it became a subsidiary of The Coca-Cola Company. Over the years, the company has expanded its product portfolio and distribution network, becoming a key player in the beverage industry.
Products and Services
Coca-Cola Amatil offers a wide range of beverages including soft drinks, bottled water, energy drinks, juices, and ready-to-drink coffee. Some of its popular brands include Coca-Cola, Sprite, Fanta, Mount Franklin, and Grinders Coffee. The company also provides vending machine services and operates a network of distribution centers to ensure efficient delivery of its products.
Operations
Coca-Cola Amatil operates in several countries across the Asia-Pacific region, including Australia, New Zealand, Indonesia, Papua New Guinea, and Fiji. The company has a strong presence in these markets and has established partnerships with local bottlers to manufacture and distribute its products. It also collaborates with various retailers and food service providers to ensure its beverages are readily available to consumers.
Sustainability Initiatives
Coca-Cola Amatil is committed to sustainability and has implemented various initiatives to reduce its environmental impact. The company focuses on water stewardship, energy efficiency, waste management, and packaging sustainability. It aims to use 100% recyclable or reusable packaging by 2025 and has set targets to reduce its carbon emissions and water usage.
Financial Performance
In 2019, Coca-Cola Amatil reported a revenue of AUD 4.4 billion, with an operating income of AUD 550 million and a net income of AUD 400 million. The company's strong financial performance reflects its market leadership and successful business strategies in the beverage industry.
References
<references group="" responsive="1"></references>
External links
Ad. Transform your life with W8MD's Budget GLP-1 injections from $49.99


W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $49.99 for the starting dose of Semaglutide and $65.00 for Tirzepatide.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointmentsNYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian